Clinical trial
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects…
NCT00478192 · Cumberland Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00478192 |
|---|---|
| Title | Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia |
| Official title | A Phase IIIb, Randomized, Double-Blind, Parallel Group, Multi-Center, Study to Assess the Efficacy and Safety of Multiple 30 Minute Infusions of YM087 (Conivaptan) in Subjects With Euvolemic or Hypervolemic Hyponatremia |
| Lead sponsor | Cumberland Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyponatremia |
| Intervention type | Drug |
| Interventions | Conivaptan, Placebo |
| Enrollment | 50 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 24, 2007 |
| Last update posted | May 15, 2014 |
| Countries | India, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: